論文

査読有り
2018年5月11日

School-age children and adolescents suspected of having been to be infected with pertussis in Japan

Vaccine
  • Yosuke Yasui
  • ,
  • Toshikatsu Mitsui
  • ,
  • Tomoyasu Nishimura
  • ,
  • Keiko Uchida
  • ,
  • Mikako Inokuchi
  • ,
  • Masaaki Mori
  • ,
  • Mitsuaki Tokumura
  • ,
  • Tetsuo Nakayama

36
20
開始ページ
2910
終了ページ
2915
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.vaccine.2018.01.048
出版者・発行元
Elsevier Ltd

Many countries including Japan have adapted acellular pertussis vaccines combined with diphtheria and tetanus toxoids (DTaP). DTaP vaccine coverage is approximately &gt
90%, but pertussis re-emergence has been observed since 2000 in Japan. In the present study, anti-pertussis antibodies were investigated among school-age children and adolescents from 2013 to 2015. The positive rate of anti-pertussis toxin (PT) antibodies was higher among children aged 12–13 years (60.0%. 95%CI
56.0–63.9%) in 2014 and 18–19 years (73.0%. 95%CI
61.4–82.6%) in 2013, compared with 6–7 years (47.1%. 95%CI
40.7–53.6%). The mean PT antibody titer was higher among children aged 12–13 years (23.8 EU/ml. 95%CI
21.9–25.8) in 2014 and 18–19 years (29.3 EU/ml. 95%CI
23.0–35.6) in 2013, compared with 6–7 years (18.3 EU/ml. 95%CI
15.5–21.2). Distributions of pertussis antibodies and mean titers at their same grade of school-age were similar from 2013 to 2015. Although school-age children were immunized with 4 doses of DTaP, the data suggested the decay of vaccine-acquired immunity and possibility of asymptomatic infection in school age, indicating the additional DTaP vaccination before the entry of elementary school, preventing household contact.

リンク情報
DOI
https://doi.org/10.1016/j.vaccine.2018.01.048
ID情報
  • DOI : 10.1016/j.vaccine.2018.01.048
  • ISSN : 1873-2518
  • ISSN : 0264-410X
  • SCOPUS ID : 85046417314

エクスポート
BibTeX RIS